SCHEMBL19857376

SCHEMBL19857376

C[C@H]1C[C@@H](O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)C[C@H]1NC(=O)O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ SSTR1 P30872 1/20 0.32
▸ SSTR4 P31391 1/20 0.32
▸ GRM1 Q13255 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ BRD4 O60885 3/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ CYP3A4 P08684 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ EPHX2 P34913 1/20 0.30
▸ TAF1 P21675 1/20 0.30
▸ BRD2 P25440 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19857373 1.00 KDM1A (0.33) KDM1AMAOBBACE1SSTR1SSTR4
SCHEMBL19857404 0.90 KDM1A (0.34) KDM1AMAOBBACE1SSTR1SSTR4
SCHEMBL4356106 0.81 KDM1A (0.43) KDM1AMAOBKMT2AMEN1EPHX2
SCHEMBL4356105 0.81 KDM1A (0.43) KDM1AMAOBKMT2AMEN1EPHX2
SCHEMBL19857400 0.81 BACE1 (0.34) BACE1GRM1SMN1; SMN2KMT2AMEN1
SCHEMBL30565037 0.80 S1PR5 (0.33) KDM1AMAOBBACE1
SCHEMBL9896982 0.80 BACE1 (0.35) KDM1AMAOBBACE1SSTR1SSTR4
SCHEMBL16224095 0.80 BACE1 (0.35) KDM1AMAOBBACE1SSTR1SSTR4
SCHEMBL9896984 0.80 BACE1 (0.35) KDM1AMAOBBACE1SSTR1SSTR4
SCHEMBL20495445 0.79 ALDH1A1 (0.37) BACE1SMN1; SMN2NPSR1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11396512-B2 CDK2/4/6 inhibitors PFIZER INC. (US) 2022-07-26 — — US disclosed
EP-3497103-B1 PYRIDOPYRIMDINONE CDK2/4/6 INHIBITORS PFIZER (US) 2021-05-05 — — EP disclosed
US-20200392142-A1 CDK2/4/6 Inhibitors PFIZER INC. (US) 2020-12-17 — — US disclosed
US-10800783-B2 CDK2/4/6 inhibitors PFIZER INC. (US) 2020-10-13 — — US disclosed
US-20190135817-A1 CDK2/4/6 Inhibitors PFIZER INC. (US) 2019-05-09 — — US disclosed
US-10233188-B2 CDK2/4/6 inhibitors PFIZER INC. (US) 2019-03-19 — — US disclosed
US-20180044344-A1 CDK2/4/6 Inhibitors PFIZER INC. (US) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392142-A1 CDK2/4/6 Inhibitors CDK2, CDK6, CDK20 KDM1A 1178/4885MAOB 1724/4885BACE1 3046/4885
US-11396512-B2 CDK2/4/6 inhibitors CDK2, CDK6, CDK20 KDM1A 1269/4885MAOB 1683/4885BACE1 3136/4885
US-10800783-B2 CDK2/4/6 inhibitors CDK2, CDK6, CDK20 KDM1A 1269/4885MAOB 1683/4885BACE1 3136/4885
US-20180044344-A1 CDK2/4/6 Inhibitors CDK2, CDK6, CDK20 KDM1A 1269/4885MAOB 1683/4885BACE1 3136/4885
US-20190135817-A1 CDK2/4/6 Inhibitors CDK2, CDK6, CDK20 KDM1A 1269/4885MAOB 1683/4885BACE1 3136/4885
US-10233188-B2 CDK2/4/6 inhibitors CDK2, CDK6, CDK20 KDM1A 1269/4885MAOB 1683/4885BACE1 3136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback